Cargando…
To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B. V
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768009/ https://www.ncbi.nlm.nih.gov/pubmed/35078128 http://dx.doi.org/10.1016/j.msard.2022.103541 |
| _version_ | 1784634826814390272 |
|---|---|
| author | Tugemann, Bastian Manouchehri, Navid Stuve, Olaf |
| author_facet | Tugemann, Bastian Manouchehri, Navid Stuve, Olaf |
| author_sort | Tugemann, Bastian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8768009 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier B. V |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87680092022-01-19 To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England Tugemann, Bastian Manouchehri, Navid Stuve, Olaf Mult Scler Relat Disord Correspondence Elsevier B. V 2022-03 2022-01-19 /pmc/articles/PMC8768009/ /pubmed/35078128 http://dx.doi.org/10.1016/j.msard.2022.103541 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Tugemann, Bastian Manouchehri, Navid Stuve, Olaf To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England |
| title | To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England |
| title_full | To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England |
| title_fullStr | To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England |
| title_full_unstemmed | To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England |
| title_short | To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England |
| title_sort | to the editors: impact of mass vaccination on sars-cov-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in england |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768009/ https://www.ncbi.nlm.nih.gov/pubmed/35078128 http://dx.doi.org/10.1016/j.msard.2022.103541 |
| work_keys_str_mv | AT tugemannbastian totheeditorsimpactofmassvaccinationonsarscov2infectionsamongmultiplesclerosispatientstakingimmunomodulatorydiseasemodifyingtherapiesinengland AT manouchehrinavid totheeditorsimpactofmassvaccinationonsarscov2infectionsamongmultiplesclerosispatientstakingimmunomodulatorydiseasemodifyingtherapiesinengland AT stuveolaf totheeditorsimpactofmassvaccinationonsarscov2infectionsamongmultiplesclerosispatientstakingimmunomodulatorydiseasemodifyingtherapiesinengland |